
LSBio, operated by LifeSpan BioSciences, Inc., is owned by Vector Laboratories, Inc., a private life science reagent company backed by Thompson Street Capital Partners. LSBio became part of Vector through the June 2024 merger of Vector Laboratories and Absolute Biotech, the holding company into which LSBio had been folded.
Parent Company
Acquired
2018
Status
Private
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| LSBio | Vector Laboratories | Subsidiary |
Drs. Joseph Brown and Glenna Burmer founded LifeSpan BioSciences in Seattle in 1995 as a molecular pathology company. Its original business was immunohistochemistry services: mapping where specific proteins sit inside diseased human tissue. Running thousands of IHC studies required generating and validating thousands of antibodies, and that accumulated testing data became the foundation of a reagent catalog.
The company transitioned from services to products, selling antibodies validated in-house through its e-commerce site lsbio.com. Its IHC-plus designation, applied to antibodies that pass the company's own tissue staining validation, became its quality marker. The catalog expanded into ELISA and immunoassay kits, proteins, biochemicals, and molecular biology reagents, targeting academic laboratories, pharmaceutical research groups, and diagnostic developers.
Thompson Street Capital Partners acquired LifeSpan BioSciences in September 2018, terms undisclosed, beginning a buy-and-build strategy. Under TSCP ownership the company acquired Nordic MUbio in 2019 and Everest Biotech in 2019, then in early 2021 completed the add-on acquisition of UK-based recombinant antibody manufacturer Absolute Antibody along with its Boston sister company Kerafast. Abacus Finance Group provided debt financing and an equity co-investment in a 2021 refinancing of the platform.
In 2022, LSBio was folded into a new umbrella identity, Absolute Biotech, which united the antibody-centric brands. The June 2024 merger with Vector Laboratories folded LSBio into an even larger reagent platform combining antibodies with Vector's protein detection, immunofluorescence, and bioconjugation product lines. As of 2026, the lsbio.com catalog lists approximately 550,000 monoclonal and polyclonal antibodies against 20,000 targets, more than 14,000 IHC-plus validated antibodies, 30,000 immunoassays, and 45,000 native and recombinant proteins.
What does Vector Laboratories own?
The company operates a brand portfolio that includes its core Vector reagent lines, LSBio (antibodies and assays), Absolute Biotech, and Quanta BioDesign (PEG chemistry), assembled through its buy-and-build strategy since 2015.
Is Vector Laboratories publicly traded?
No. Vector Laboratories is privately held by private equity firm Thompson Street Capital Partners, which acquired a majority stake in 2015. It has no stock listing.
Who founded Vector Laboratories?
Jim Whitehead founded the company in 1976 in Burlingame, California, commercializing avidin-biotin detection chemistry for immunohistochemistry. The company relocated to Newark, California, where it is still based.
Where is Vector Laboratories headquartered?
The company's headquarters and primary manufacturing site is at 30 Ingold Road, Newark, California, in the East Bay. It operates additional sites in Seattle, San Diego, Atlanta, Absam (Austria), and the UK through its brands.
How many brands does Vector Laboratories own?
Four principal brands: Vector Laboratories core reagents, LSBio, Absolute Biotech, and Quanta BioDesign, plus associated product families such as ImmPACT substrates.
Who owns Vector Laboratories?
Thompson Street Capital Partners, a St. Louis private equity firm, holds the controlling stake acquired in 2015. Management and prior owners may retain minority positions; the company does not disclose its cap table.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Regeneron | USA | 1988 | Premium | United states | All Genders |
Market Positioning: LSBio competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Vector Laboratories, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Regeneron Pharmaceuticals, Inc.
Biotechnology brand of Regeneron Pharmaceuticals, developer of Eylea, Dupixent, and Libtayo, headquartered in Tarrytown, New York.
Regeneron operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by ADARx Pharmaceuticals, Inc.
Biotechnology brand of ADARx Pharmaceuticals, the San Diego siRNA company that listed on Nasdaq in September 2026.
ADARx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
Amgen operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Danaher Corporation
The master brand of Danaher Corporation, covering the life sciences and diagnostics instruments and consumables that power its operating companies.
Danaher operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Pfizer Inc.
American multinational pharmaceutical corporation developing and manufacturing medicines, vaccines, and consumer healthcare products, one of the world's largest pharmaceutical companies.
Pfizer operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.